U.S. Cardiology Procedures Market To witness Huge Expansion By 2030

U.S. Cardiology Procedures Market Summary

The U.S. cardiology procedures market size was estimated at USD 55.01 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2030. Several key factors are fueling this market growth, including the increasing proportion of the aging population, the rising prevalence of cardiovascular diseases (CVDs), and continuous advancements in cardiology-related device technologies. As the elderly population grows, the incidence of cardiac conditions tends to increase, leading to greater demand for diagnostic and therapeutic cardiology procedures. Moreover, the ongoing surge in clinical research aimed at developing advanced cardiovascular treatments is expected to present significant opportunities for market expansion throughout the forecast period.

The prevalence of CVDs in the U.S. continues to rise, contributing substantially to the demand for cardiology procedures. Conditions such as coronary artery disease (CAD), heart arrhythmias, heart failure, heart valve disorders, congenital heart defects, cardiomyopathy, and pericardial disease are becoming increasingly common among adults. According to the Centers for Disease Control and Prevention (CDC), approximately 20.5 million adults in the United States were living with CAD in 2023, making it the most widespread form of heart disease. This growing disease burden underscores the critical need for early diagnosis, continuous monitoring, and timely intervention through advanced cardiology procedures.

Key Market Trends & Insights

• In terms of procedural categories, the interventional procedures segment led the U.S. cardiology procedures market in 2023, accounting for the largest revenue share of 53.74%. This dominance is attributed to the increasing adoption of minimally invasive techniques that offer faster recovery times, reduced hospital stays, and improved patient outcomes. Interventional procedures include coronary angioplasty, stent placements, and catheter-based interventions that are particularly beneficial for patients with blocked or narrowed coronary arteries. Moreover, this segment is anticipated to register the fastest growth rate, with a projected CAGR of 8.1% from 2024 to 2030, driven by innovations in imaging technology, catheter design, and real-time navigation systems.
• According to the American College of Cardiology, around 1.2 million angioplasties were performed across the U.S. in 2023. This high number reflects a growing reliance on angioplasty as a frontline treatment for CAD. Several lifestyle-related factors such as poor dietary habits, lack of physical activity, rising obesity rates, and increasing incidence of diabetes are key contributors to the growing burden of CAD. These risk factors are not only elevating the demand for angioplasties but also increasing the overall number of interventional cardiology procedures performed annually in both inpatient and outpatient settings.

Order a free sample PDF of the U.S. Cardiology Procedures Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2023 Market Size: USD 55.01 billion
• 2030 Projected Market Size: USD 92.32 billion
• CAGR (2024 - 2030): 7.7%

Key Companies & Market Share Insights

Key U.S. cardiology procedures hospitals include Cleveland Clinic, Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Stanford Health Care, Cedars-Sinai Medical Center, and Northwestern Memorial Hospital.

Key Players

• Cleveland Clinic
• Mayo Clinic
• Johns Hopkins Hospital
• Massachusetts General Hospital
• Stanford Health Care
• Cedars-Sinai Medical Center
• Northwestern Memorial Hospital

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. cardiology procedures market is poised for strong growth due to rising cardiovascular disease prevalence, a growing elderly population, and technological advancements in minimally invasive interventions. Interventional procedures such as angioplasties are becoming increasingly common as they offer quicker recovery and reduced complications. Supportive clinical research and innovations in imaging and catheter systems are enhancing procedural accuracy and patient care. With lifestyle-related risk factors on the rise, demand for early diagnosis and effective treatment is accelerating. As the need for efficient cardiac care continues to climb, the market will play a pivotal role in shaping future cardiovascular health outcomes.